Analysis of change in PM alone showed a benefit to the intervention group (three studies, N = 340, SMD = −0.33, CI: [−0.62, −0.05], p = 0.02), while analysis of change in air nicotine alone showed a trend towards a benefit to the intervention group (air nicotine change: four studies, N = 421, p = 0.08).
The NL3 R451C mice paired with the same genotype mice showed a trend for reduced social interaction compared to the WT/WT pairs ( p = 0.08) and compared to the NL3 R451C mice paired with WT mice ( p = 0.058).
Correlations At POST1, Pearson correlation analysis showed a trend toward a relationship between the reduction in MVC force and the reduction in P100 Hz ( r = 0.44, p = 0.08), but without reaching the level of significance.
Patients treated with rosuvastatin had a 51% lower risk of CI-AKI compared with the control group based on a fixed-effect model (OR = 0.49, 95% CI = 0.37–0.66, P < 0.001), and showed a trend toward a reduced risk of MACEs (OR = 0.62, 95% CI = 0.36–1.07, P = 0.08).
In 5 trials, n = 1301) at risk for cardiovascular disease (coronary artery disease, acute coronary syndrome or stroke, post-angioplasty [2 RCTs], or congestive heart failure), colchicine reduced composite cardiovascular outcomes by ~60 % (risk ratio [RR] 0.44, 95 % confidence interval [CI] 0.28-0.69, p = 0.0004; I 2 = 0 %) and showed a trend towards lower all-cause mortality (RR 0.50, 95 % CI 0.23-1.08, p = 0.08; I 2 = 0 %).
Old items were also associated with significantly lower confidence than Control items (Agentic Subject: t (17) = 4.30, P = 0.0005; Agentic Experimenter: t (17) = 6.28, P = 0.000008; Conceptual Obama: t (17) = 4.93, P = 0.0001), with the exception of items that the participant had related to themselves during study, which only showed a trend for lower confidence (Conceptual You: t (17) = 1.89, P = 0.08).
In a multivariate Cox regression model including age, tumor size, stage, and PD-L1 expression status, the latter three factors were found to be independent predictors of PFS ( P =0.023, P =0.000, and P =0.009, respectively), but only stage was found to be an independent factor for OS ( P =0.007), and PD-L1 expression status showed a trend to be independently correlated with OS ( P =0.080).
Overall, the changes in serum FAM84B protein level showed a trend toward association with pathological response ( p = 0.08).
MANOVA showed a trend for a significant group effect for placebo ( F (df = 8,114); p < 0.08), which was due to increased omission errors between controls and patients under placebo ( F (df = 2,61) = 4, p < 0.02).
Individuals with mtDNA haplotype D did not show association with the IRF6 alleles ( P = 0.259), but individuals with mtDNA haplotypes other than haplotype D showed a trend for association with IRF6 ( P = 0.08).
Hemoglobin levels showed a trend (RR 1.76; 95%-CI 0.94-3.26; p = 0.08), and extent of resection was not significant (RR 1.81; 95%-CI 0.88-3.52; p = 0.11).
After adjustment, new MRA use was not associated with reduced AF progression (hazard ratio, 1.18; 95% confidence interval, 0.88–1.58; P =0.27) but showed a trend towards lower risk of stroke, transient ischemic attack, or systemic embolism (hazard ratio, 0.17; 95% confidence interval, 0.02–1.23; P =0.08).
Findings were confirmed by the MADRS suicide item (r = .55, P = .02) and showed a trend on the SSI-5 (r = .41, P = .08).
Younger women (≤50 years) showed a trend towards a higher prevalence of plaque erosion compared to men of the same age (74% vs. 53%, p = 0.08), while both sexes experienced a similar decline in plaque erosion with ageing (27% in women vs. 32% in men >80 years).
The electrophysiological and clinical CR effects, observed in all six patients (reduction of LFP beta activity by 48% and of UPDRS motor scores by 58% compared with baseline), were cumulative; that is, after the third daily dose of CR neuromodulation (in the evening of day 3) UPDRS motor scores showed a significant improvement ( P = 0.03), and beta activity showed a trend toward a significant reduction ( P = 0.08) compared with the evening of the first day.
Repeat analysis excluding initial failures showed a trend for better 1-year primary patency rates of primary procedures (100 vs 57%, for staged procedures, P = 0.08); however, 1-year assisted-primary and secondary patency rates of primary and staged procedures were equivalent (100 vs 71%, P = 0.27, and 100 vs 86%, P = 0.45, respectively).
The univariate regression analysis showed a trend between fatigue and GMFCS level (p = 0.08).
anserina , a spirochete from the relapsing fever clade causing avian borreliosis, both showed a trend towards loss of motility after incubation with NHS compared to HIS (p = 0.08).
Combining EZH2 and SUZ12 showed a trend for DFS in multivariate analyses, with p = 0.08 (HR = 0.77; 95% CI 0.57–1.04).
Spectrin 120 was not significantly changed in either wildtype or HIF-1α knockout after HI, but the HIF-1α knockout cortex showed a trend toward more spectrin 120 than wildtype at 24 h ( Figure 5b , p=0.08).
uPA −/− mice showed a trend towards more severe renal impairment (sCr P = 0.08 compared to WT).
24 , 25 , 93 , 94 To that end, one small retrospective non-randomized study in TBI evaluated cognitive performance and showed a trend toward improved outcomes among patients treated with LEV versus PHT ( P =0.08). 25 Finally, a single-blinded RCT has shown better Glasgow Outcome Scale and modified Rankin Scale outcomes in patients with moderate or severe TBI who were treated with LEV versus PHT. 24 Evidence for seizures after bra
High ruminators, compared to low ruminators, showed a trend for shorter fixation times for pictures of the deceased combined with a loss-related word, F (1,37) = 2.02, p = .08, p η 2 = .05.
Subgroup analysis of septic and non-septic patients showed a trend of higher A-FABP serum levels in the septic patients ( P = 0.08), especially in those with septic shock (median 53.25 ng/ml versus 35.13 ng/ml in non-shock patients, P = 0.004).
Spectral analysis showed a trend toward an increased low-frequency to high-frequency ratio in patients (p = 0.08) suggesting sympathetic predominance.